logo

For the Inventor, By the Inventor

Spring House, PA, United States of America

Rifat Pamukcu

This inventor holds 74 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Neoplasia Treatment (CPC class A61K). Top assignees: Cell Pathways, The University of Arizona, Osi Pharmaceuticals, Inc.. Active years: 1995-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rifat Pamukcu. Retrieved from https://idiyas.com/inventor/rifat-pamukcu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 74 

% Patents Active = 85.1

 

Average Co-Inventor Count = 2.4

ph-index = 15

Forward Citations = 837(Granted Patents)

Forward Citations (Not Self Cited) = 766(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Cincinnati, OH (US) (1995 - 1998)
  • Spring House, PA (US) (1997 - 2018)

Company Filing History:

goldMedal67 out of 75 
 
Cell Pathways
 patents
silverMedal7 out of 1,060 
 
The University of Arizona
 patents
bronzeMedal3 out of 118 
 
Osi Pharmaceuticals, Inc.
 patents
4. 1 out of 1 
 
Fgn, Inc.
 patent
5. 1 out of 1,439 
 
Michigan State University
 patents
6. 1 out of 1 
 
Midway Pharmaceuticals, Inc
 patent
7. 2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1995-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Neoplasia
Indole Derivatives
Platinum Coordination Complex
Precancerous Lesions
Vinca Alkaloid Derivatives
Phenyl Quinazolinone
Benzimidazole Derivatives
Pharmaceutical Compositions
Therapeutic Compounds
Cancer Treatment
Diagnostic Methods
HMW PEG
74 patents (USPTO):Explore Patents
1. 10045949 - Managing osteoporosis with HMW PEG (2018-08-14),
2. 7115647 - Method of inhibiting neoplastic cells with indole derivatives (2006-10-03),
3. 6875575 - Diagnostic methods for neoplasia (2005-04-05),
4. 6869944 - Method for treating a patient with neoplasia by treatment with a platinum coordination complex (2005-03-22),
5. 6610854 - Substituted condensation products of N-benzyl-3-indenylacentamides with heterocyclic aldehydes for neoplasia (2003-08-26),
6. 6562830 - Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives (2003-05-13),
7. 6555547 - Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative (2003-04-29),
8. 6500610 - Methods for identifying compounds for inhibiting of neoplastic lesions, and pharmaceutical compositions containing such compounds (2002-12-31),
9. 6486158 - [4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia (2002-11-26),
10. 6486155 - Method of inhibiting neoplastic cells with isoquinoline derivatives (2002-11-26),
11. 6479520 - Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives (2002-11-12),
12. 6472420 - Method for treating a patient with neoplasia by treatment with a paclitaxel derivative (2002-10-29),
13. 6455703 - 1,3,6,-Trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia (2002-09-24),
14. 6440981 - Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones (2002-08-27),
15. 6432950 - Method for inhibiting neoplastic cells and related conditions by exposure to benzothienopyrimidine derivatives (2002-08-13),

Title: Rifat Pamukcu: A Pioneer in Medical Innovations

Introduction

Rifat Pamukcu, based in Spring House, PA, is a distinguished inventor holding an impressive 74 patents. His work primarily focuses on advancing medical treatments and enhancing the healthcare industry through innovative solutions.

Latest Patents

Among his notable contributions, Rifat’s latest patents include methods for managing osteoporosis using high molecular weight polyethylene glycol compositions. This invention is aimed at improving gastrointestinal health while promoting growth performance and addressing conditions such as osteopenia and osteoporosis.

Another significant patent involves a method for inhibiting neoplastic cells through the use of substituted indole derivatives. This invention represents a crucial step towards developing targeted therapies for cancer and related conditions.

Career Highlights

Rifat Pamukcu has made substantial contributions in his field while collaborating with prominent organizations. He has notably worked with Cell Pathways, a company dedicated to pioneering cancer therapies, and The University of Arizona, where he has engaged in research and development activities that further enhance the medical landscape.

Collaborations

Throughout his career, Rifat has collaborated with esteemed colleagues like Gary A. Piazza and Gerhard J. Sperl. These partnerships have fostered a dynamic environment for innovation and have significantly influenced the advancements in their respective fields.

Conclusion

Rifat Pamukcu’s expertise and extensive patent portfolio underscore his influential role as an inventor. Through his innovative solutions and collaborative efforts, he continues to contribute meaningfully to medical advancements and the improvement of patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…